细胞淋巴瘤-话题@MedSci

#细胞淋巴瘤#

385篇内容 | 5337人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1702612, encodeId=9b7a1e0261201, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=邱录贵教授：利妥昔单抗是淋巴瘤免疫化疗的“基石”药物，为惰性B细胞淋巴瘤带来显著生存获益丨2020年白血病·淋巴瘤高峰论坛, objectType=article, longId=186322, objectId=1d521863220b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d521863220b, replyNumber=0, likeNumber=71, createdTime=2020-08-13, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d521863220b, moduleTitle=邱录贵教授：利妥昔单抗是淋巴瘤免疫化疗的“基石”药物，为惰性B细胞淋巴瘤带来显著生存获益丨2020年白血病·淋巴瘤高峰论坛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d521863220b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702608, encodeId=c1131e02608ec, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：儿童侵袭性成熟B细胞淋巴瘤（2020.V1）, objectType=article, longId=185482, objectId=aa7a18548291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa7a18548291, replyNumber=0, likeNumber=20, createdTime=2020-01-01, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa7a18548291, moduleTitle=NCCN临床实践指南：儿童侵袭性成熟B细胞淋巴瘤（2020.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa7a18548291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702652, encodeId=8ff51e0265267, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Lancet Haematol：CD20单抗Obinutuzumab联合DHAP治疗套细胞淋巴瘤的疗效, objectType=article, longId=201580, objectId=a894201580eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a894201580eb, replyNumber=0, likeNumber=103, createdTime=2021-04-10, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a894201580eb, moduleTitle=Lancet Haematol：CD20单抗Obinutuzumab联合DHAP治疗套细胞淋巴瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a894201580eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702632, encodeId=20ca1e026320a, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Truxima、来那度胺和acalabrutinib方案治疗复发难治性侵袭性B细胞淋巴瘤：安全有效, objectType=article, longId=196009, objectId=77a7196009ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77a7196009ec, replyNumber=0, likeNumber=68, createdTime=2021-03-02, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77a7196009ec, moduleTitle=Truxima、来那度胺和acalabrutinib方案治疗复发难治性侵袭性B细胞淋巴瘤：安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77a7196009ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702609, encodeId=c51b1e0260981, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：两种新外周T细胞淋巴瘤亚型：PTCL-GATA3和PTCL-TBX21, objectType=article, longId=185587, objectId=0f9018558e8f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f9018558e8f, replyNumber=0, likeNumber=143, createdTime=2020-04-05, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f9018558e8f, moduleTitle=Blood：两种新外周T细胞淋巴瘤亚型：PTCL-GATA3和PTCL-TBX21, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f9018558e8f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702640, encodeId=10721e0264045, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=多细胞因子抑制剂BNZ-1治疗皮肤T细胞淋巴瘤：安全性和有效性良好, objectType=article, longId=197837, objectId=879319e8373b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=879319e8373b, replyNumber=0, likeNumber=126, createdTime=2020-12-31, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=879319e8373b, moduleTitle=多细胞因子抑制剂BNZ-1治疗皮肤T细胞淋巴瘤：安全性和有效性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=879319e8373b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702597, encodeId=2ef41e025976a, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：原发性纵隔大B细胞淋巴瘤全基因组分析揭示新的致病变异, objectType=article, longId=182129, objectId=70891821292f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70891821292f, replyNumber=0, likeNumber=51, createdTime=2020-07-02, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70891821292f, moduleTitle=Blood：原发性纵隔大B细胞淋巴瘤全基因组分析揭示新的致病变异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70891821292f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702623, encodeId=bbe01e026239d, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Lancet Haematol：过去十年，结外自然杀伤T细胞淋巴瘤的治疗进展, objectType=article, longId=189131, objectId=df8e18913157, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df8e18913157, replyNumber=0, likeNumber=68, createdTime=2020-03-10, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df8e18913157, moduleTitle=Lancet Haematol：过去十年，结外自然杀伤T细胞淋巴瘤的治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df8e18913157)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702621, encodeId=702a1e026210c, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=FDA接受Karyopharm的口服核出口选择性抑制剂XPOVIO的补充新药申请，用于治疗复发或难治的弥漫性大B细胞淋巴瘤, objectType=article, longId=188486, objectId=9acb18848624, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9acb18848624, replyNumber=0, likeNumber=71, createdTime=2020-06-26, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9acb18848624, moduleTitle=FDA接受Karyopharm的口服核出口选择性抑制剂XPOVIO的补充新药申请，用于治疗复发或难治的弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9acb18848624)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702592, encodeId=c6e11e025920a, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=儿童成熟B细胞淋巴瘤诊疗规范（2019年版）, objectType=article, longId=179762, objectId=4ccd1e97623b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ccd1e97623b, replyNumber=0, likeNumber=22, createdTime=2019-10-13, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ccd1e97623b, moduleTitle=儿童成熟B细胞淋巴瘤诊疗规范（2019年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ccd1e97623b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702622, encodeId=355b1e0262293, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2020.V1）, objectType=article, longId=188974, objectId=ae461889e4c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae461889e4c5, replyNumber=0, likeNumber=22, createdTime=2020-12-25, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae461889e4c5, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2020.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae461889e4c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702589, encodeId=dfe11e02589fd, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=儿童淋巴母细胞淋巴瘤诊疗规范（2019年版）, objectType=article, longId=179648, objectId=30001e96482a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30001e96482a, replyNumber=0, likeNumber=29, createdTime=2020-07-28, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30001e96482a, moduleTitle=儿童淋巴母细胞淋巴瘤诊疗规范（2019年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30001e96482a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702598, encodeId=fb7e1e0259840, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Mallinckrodt的UVADEX（甲氧沙林）获得澳大利亚批准，与THERAKOS CELLEX光电穿刺系统联合治疗成人慢性移植物抗宿主疾病和T细胞淋巴瘤, objectType=article, longId=182364, objectId=2e5e18236425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e5e18236425, replyNumber=0, likeNumber=64, createdTime=2020-05-04, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e5e18236425, moduleTitle=Mallinckrodt的UVADEX（甲氧沙林）获得澳大利亚批准，与THERAKOS CELLEX光电穿刺系统联合治疗成人慢性移植物抗宿主疾病和T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e5e18236425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702639, encodeId=87e01e026397f, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：采用R-CHOP治疗的原发性纵隔大B细胞淋巴瘤(PMBCL) 的预后, objectType=article, longId=197418, objectId=96e319e4187d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96e319e4187d, replyNumber=0, likeNumber=116, createdTime=2021-02-01, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96e319e4187d, moduleTitle=Blood：采用R-CHOP治疗的原发性纵隔大B细胞淋巴瘤(PMBCL) 的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96e319e4187d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702602, encodeId=e31e1e02602f1, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=复发难治套细胞淋巴瘤MCL治疗安全有效, objectType=article, longId=184344, objectId=004a184344b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=004a184344b5, replyNumber=0, likeNumber=61, createdTime=2020-03-20, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=004a184344b5, moduleTitle=复发难治套细胞淋巴瘤MCL治疗安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=004a184344b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702584, encodeId=1af01e02584c0, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2020.V1）, objectType=article, longId=178897, objectId=ead91e8897ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ead91e8897ba, replyNumber=0, likeNumber=28, createdTime=2019-12-06, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ead91e8897ba, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2020.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ead91e8897ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702635, encodeId=ed8a1e02635c2, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：IL10RA调控NPM1-ALK+间变性大细胞淋巴瘤对克唑替尼的敏感性, objectType=article, longId=196880, objectId=a6fb196880ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6fb196880ea, replyNumber=0, likeNumber=79, createdTime=2021-05-14, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6fb196880ea, moduleTitle=Blood：IL10RA调控NPM1-ALK+间变性大细胞淋巴瘤对克唑替尼的敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6fb196880ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702618, encodeId=ad5f1e02618f2, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=J Gastroenterology：PD-L1表达对原发性胃和肠弥漫性大B细胞淋巴瘤的预后影响, objectType=article, longId=187601, objectId=3fc418e60132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fc418e60132, replyNumber=0, likeNumber=69, createdTime=2020-07-05, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fc418e60132, moduleTitle=J Gastroenterology：PD-L1表达对原发性胃和肠弥漫性大B细胞淋巴瘤的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fc418e60132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702619, encodeId=c1251e026197a, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Cell Death Dis：新型HDAC抑制剂西达本胺可与利妥昔单抗协同抑制弥漫性大B细胞淋巴瘤, objectType=article, longId=187714, objectId=782818e714bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=782818e714bf, replyNumber=0, likeNumber=106, createdTime=2020-10-17, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=782818e714bf, moduleTitle=Cell Death Dis：新型HDAC抑制剂西达本胺可与利妥昔单抗协同抑制弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=782818e714bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702591, encodeId=d6091e02591cb, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=回肠弥漫大B细胞淋巴瘤超声表现1例, objectType=article, longId=179721, objectId=b5a31e9721f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5a31e9721f9, replyNumber=0, likeNumber=74, createdTime=2020-08-17, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5a31e9721f9, moduleTitle=回肠弥漫大B细胞淋巴瘤超声表现1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5a31e9721f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞淋巴瘤

2020-05-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

邱录贵教授：利妥昔单抗是淋巴瘤免疫化疗的“基石”药物，为惰性B细胞淋巴瘤带来显著生存获益丨2020年白血病·淋巴瘤高峰论坛

2020-08-13

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：儿童侵袭性成熟B细胞淋巴瘤（2020.V1）

2020-01-01

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Lancet Haematol：CD20单抗Obinutuzumab联合DHAP治疗套细胞淋巴瘤的疗效

2021-04-10

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Truxima、来那度胺和acalabrutinib方案治疗复发难治性侵袭性B细胞淋巴瘤：安全有效

2021-03-02

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：两种新外周T细胞淋巴瘤亚型：PTCL-GATA3和PTCL-TBX21

2020-04-05

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

多细胞因子抑制剂BNZ-1治疗皮肤T细胞淋巴瘤：安全性和有效性良好

2020-12-31

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：原发性纵隔大B细胞淋巴瘤全基因组分析揭示新的致病变异

2020-07-02

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Lancet Haematol：过去十年，结外自然杀伤T细胞淋巴瘤的治疗进展

2020-03-10

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

FDA接受Karyopharm的口服核出口选择性抑制剂XPOVIO的补充新药申请，用于治疗复发或难治的弥漫性大B细胞淋巴瘤

2020-06-26

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

儿童成熟B细胞淋巴瘤诊疗规范（2019年版）

2019-10-13

爆笑小医 (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：B细胞淋巴瘤（2020.V1）

2020-12-25

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

儿童淋巴母细胞淋巴瘤诊疗规范（2019年版）

2020-07-28

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Mallinckrodt的UVADEX（甲氧沙林）获得澳大利亚批准，与THERAKOS CELLEX光电穿刺系统联合治疗成人慢性移植物抗宿主疾病和T细胞淋巴瘤

2020-05-04

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：采用R-CHOP治疗的原发性纵隔大B细胞淋巴瘤(PMBCL) 的预后

2021-02-01

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

复发难治套细胞淋巴瘤MCL治疗安全有效

2020-03-20

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2020.V1）

2019-12-06

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：IL10RA调控NPM1-ALK+间变性大细胞淋巴瘤对克唑替尼的敏感性

2021-05-14

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

J Gastroenterology：PD-L1表达对原发性胃和肠弥漫性大B细胞淋巴瘤的预后影响

2020-07-05

docwu2019 (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Cell Death Dis：新型HDAC抑制剂西达本胺可与利妥昔单抗协同抑制弥漫性大B细胞淋巴瘤

2020-10-17

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

回肠弥漫大B细胞淋巴瘤超声表现1例

2020-08-17

科室
- - 订阅+
  - 更多科室
工具
服务